Event Details 06.06.2018 8:00 AM EDT Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition Click here for webcast Email Alerts RSS Feeds Investor Contact
06.06.2018 8:00 AM EDT Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition Click here for webcast
